Colonial River Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-927
Closed -$299K 207
2024
Q3
$299K Sell
927
-2,822
-75% -$923K 0.15% 151
2024
Q2
$1.17M Buy
3,749
+486
+15% +$143K 0.63% 47
2024
Q1
$928K Buy
3,263
+1,512
+86% +$442K 0.52% 58
2023
Q4
$504K Buy
1,751
+441
+34% +$120K 0.3% 97
2023
Q3
$352K Buy
+1,310
New +$327K 0.23% 109
2023
Q2
Sell
-1,089
Closed -$263K 172
2023
Q1
$263K Buy
1,089
+326
+43% +$80K 0.15% 152
2022
Q4
$200K Buy
+763
New +$205K 0.13% 177

Other funds holding AMGN

Colonial River Investments's AMGN Position: Q4 2024 in Review

Colonial River Investments sold out of Amgen (AMGN) in Q4 2024, closing a stake of 927 shares — an estimated $299K sold.

Colonial River Investments first reported a position in AMGN in Q4 2022 and held it in 7 quarters. The position peaked at $1.17M in Q2 2024. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Colonial River Investments reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Colonial River Investments sold 927 Amgen shares in Q4 2024, an estimated $299K.
  • Colonial River Investments first reported a position in Amgen in Q4 2022 and held it in 7 quarters.
  • Colonial River Investments's Amgen position peaked at $1.17M in Q2 2024.
  • 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Colonial River Investments's 13F filing for Q4 2024, filed 4 Feb 2025.